Important safety information related to taking CRYSVITA® (burosumab-twza)
Learn about the potential side effects related to taking CRYSVITA
Learn about the potential side effects related to taking CRYSVITA
The following side effects were observed in 10% or more of children who were treated with CRYSVITA across all studies.
Muscle pain and dizziness were also observed in more than 10% of children receiving CRYSVITA in Studies 2 and 3.
These are not all the possible side effects of CRYSVITA. Call your doctor for medical advice about side effects.
You may report side effects to the FDA at (800) FDA-1088 or www.fda.gov/medwatch. You may also report side effects to Ultragenyx at 1-888-756-8657.
Please see full Prescribing Information for additional Important Safety Information.
The following side effects were observed in more than 5% of adults who were treated with CRYSVITA every 4 weeks and in at least 2 patients more than with placebo in the first 24 weeks of Study 4.
Narrowing of the spaces within the spine is common in adults with XLH, and pressure on the spinal cord has been reported in adults taking CRYSVITA. It is not known if taking CRYSVITA worsens the narrowing of the spaces within the spine or the pressure on the spinal cord.
These are not all the possible side effects of CRYSVITA. Call your doctor for medical advice about side effects.
You may report side effects to the FDA at (800) FDA-1088 or www.fda.gov/medwatch. You may also report side effects to Ultragenyx at 1-888-756-8657.
Please see full Prescribing Information for additional Important Safety Information.